Implementation of a pharmacological prophylaxis bundle to prevent obstetric-associated venous thromboembolism
American Journal of Health-System Pharmacy · 2023
DOI: 10.1093/ajhp/zxac308 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Health-System Pharmacy, 2023. Verfasst von Ronald E Iverson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA. Hauptthemen laut MEDLINE: Venous Thromboembolism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
Purpose
Venous thromboembolism (VTE) accounts for a significant proportion of pregnancy-related mortality. In response to a series of VTEs at our institution and in accordance with mounting medical evidence for increased assessment, we implemented a universal, standardized obstetric VTE risk assessment process during antepartum and postpartum admissions and corresponding pharmacological thromboprophylaxis, which extends into the postdischarge period to prevent pregnancy-associated VTE in our urban, safety-net population. Summary This quality improvement (QI) project used the Institute for Healthcare Improvement’s Model for Improvement. We analyzed data from chart audits, patient and pharmacy outreach, and electronic reports using statistical process control charts. A review of 407 charts showed an increase in the proportion of patients undergoing documented risk assessment from 0% to 80% (average of 61%) from July 2015 to June 2016. The average risk assessment rate increased from 61% to 98% from July 2016 through March 2021 after the screening was integrated into the electronic health record (EHR). Rate of receipt of recommended thromboprophylaxis during admission increased from an average of 85% before EHR integration to 94% after integration. The proportion of high-risk patients receiving prescriptions upon discharge increased from 7% before EHR integration to 87% after integration. We interviewed 117 patients by telephone, of whom 74% continued the medications at home.
Conclusion
An interprofessional team can achieve high rates of obstetric inpatient VTE risk assessment, pharmacological thromboprophylaxis initiation, and outpatient continuation using QI methodology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
- Boston Medical Center, Boston, MA, USA.
- Public Consulting Group, Denver, CO, USA.
- myPlace Health, New York, NY,USA.
- Boston University Chobanian & Avedisian School of Medicine, MA, USA.
- Novant Health Rankin, Charlotte, NC, USA.
Zitieren
APA
Iverson, R. E., Zhang, M., Jansen, E. M., Trucks, E., Iorio, R., Combs, G., Kourtelidis, M., Mottl-Santiago, J., Norris, M., Lambert, L., Katzmark, R., Vyas, P., & Abbott, J. F. (2023). Implementation of a pharmacological prophylaxis bundle to prevent obstetric-associated venous thromboembolism. American Journal of Health-System Pharmacy. https://doi.org/10.1093/ajhp/zxac308
Vancouver
Iverson RE, Zhang M, Jansen EM, Trucks E, Iorio R, Combs G, et al. Implementation of a pharmacological prophylaxis bundle to prevent obstetric-associated venous thromboembolism. American Journal of Health-System Pharmacy. 2023. doi:10.1093/ajhp/zxac308
BibTeX
@article{Iverson2023,
author = {Iverson, Ronald E and Zhang, Min and Jansen, Emily M and Trucks, Emma and Iorio, Rhiannon and Combs, Ginny and Kourtelidis, Marie and Mottl-Santiago, Julie and Norris, Mark and Lambert, Lynne and Katzmark, Rachel and Vyas, Pooja and Abbott, Jodi F},
title = {Implementation of a pharmacological prophylaxis bundle to prevent obstetric-associated venous thromboembolism},
journal = {American Journal of Health-System Pharmacy},
year = {2023},
doi = {10.1093/ajhp/zxac308}
}
EUVIMED